Florida Cancer Specialists & Research Institute and Humana Inc. have signed a new multiyear agreement that provides Humana members with in-network access to FCS’ comprehensive range of oncology services.
Florida Cancer Specialists & Research Institute (FCS) and Humana Inc. (NYSE: HUM) have signed a new multiyear agreement that provides Humana members with in-network access to FCS’ comprehensive range of oncology services.
Beginning October 1, 2019, the agreement adds services at FCS locations throughout the state. Humana members with coverage provided through Medicare, Medicaid, and commercial plans can receive oncology and hematology physician services, as well as radiation oncology, radiology, laboratory, pathology, and pharmacy services at in-network rates.
FCS Chief Executive Officer Brad Prechtl, MBA said, “We are so pleased to welcome Humana members. This agreement means that even more Florida residents can now access FCS providers and services and receive world-class cancer care, as well as treatments for other non-cancer related illnesses, close to where they live and work.”
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More